Who invested in Belharra Therapeutics?
Belharra Therapeutics's investors include Versant Ventures.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2023, from 1 source
Belharra Therapeutics's investors include Versant Ventures.
Belharra Therapeutics has raised $50M across 1 round since 2023.
Belharra Therapeutics's most recent round was a Series A of $50M in Jan 2023.
Its most recent round, $50M in Jan 2023, is also its largest on record.
Belharra Therapeutics's first round on record, in Jan 2023, was backed by Versant Ventures.
Belharra Therapeutics's latest named round is a Series A, in Jan 2023.
Belharra Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.